Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine
Link
http://academic.oup.com/bja/article-pdf/101/4/492/819885/aen216.pdf
Reference25 articles.
1. New neuromuscular blocking drugs;Hunter;N Engl J Med,1995
2. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium;Caldwell;Anesth Analg,1995
3. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium;Berg;Acta Anaesthesiol Scand,1997
4. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade;Kirkegaard-Nielsen;Can J Anaesth,1996
5. Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol;Reid;Can J Anaesth,2001
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of Neuromuscular Blocking and Antagonism Agents across the Spectrum of Renal Impairment Undergoing Major Inpatient Surgery: A Single-center Retrospective Observational Cohort Study;Anesthesiology;2024-08-08
2. Sugammadex use in pediatric patients with stage IV-V chronic kidney disease in a quaternary referral hospital: a case series;BMC Anesthesiology;2024-06-10
3. Effect of Changing Estimated Glomerular Filtration Rate Formula on Sugammadex Use and Pulmonary Complications for African American and non-African American Patients;Anesthesia & Analgesia;2024-02-12
4. Residual Neuromuscular Block Remains a Safety Concern for Perioperative Healthcare Professionals: A Comprehensive Review;Journal of Clinical Medicine;2024-02-01
5. Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Patients With Severe Renal Impairment: A Randomized, Double-Blinded Study;Anesthesia & Analgesia;2024-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3